ArticleFrontiers in oncology2022

Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy.

Yu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.